OrbiMed’s Societal CDMO, Inc. Common Stock SCTL Stock Holding History

OrbiMed’s Portfolio SCTL Stock Details SCTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-48,501	Closed	-$255K	–	138
2019 Q1	$255K	Sell	48,501 -71,202	-59%	-$528K	﹤0.01%	123
2018 Q4	$762K	Hold	119,703	–	–	0.01%	125
2018 Q3	$763K	Hold	119,703	–	–	0.01%	146
2018 Q2	$539K	Buy	+119,703	New	+$950K	0.01%	144

Other funds holding SCTL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

OrbiMed's SCTL Position: Q2 2019 in Review

OrbiMed sold out of Societal CDMO, Inc. Common Stock (SCTL) in Q2 2019, closing a stake of 48,501 shares — an estimated $255K sold.

OrbiMed first reported a position in SCTL in Q2 2018 and held it in 4 quarters. The position peaked at $763K in Q3 2018. 81 funds tracked by Wall St. Rank hold SCTL as of Q2 2019.

OrbiMed reported no remaining Societal CDMO, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
OrbiMed sold 48,501 Societal CDMO, Inc. Common Stock shares in Q2 2019, an estimated $255K.
OrbiMed first reported a position in Societal CDMO, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
OrbiMed's Societal CDMO, Inc. Common Stock position peaked at $763K in Q3 2018.
81 funds tracked by Wall St. Rank held Societal CDMO, Inc. Common Stock as of Q2 2019.

Based on OrbiMed's 13F filing for Q2 2019, filed 14 Aug 2019.